Abstract
Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Mohammed A Muzaffer, Jean-Michel Dayer, Brian M Feldman, Waldemar Pruzanski, Pascale Roux-Lombard, Rayfel Schneider, Ronald M Laxer and Earl D Silverman
The Journal of Rheumatology May 2002, 29 (5) 1071-1078;
Mohammed A Muzaffer
Jean-Michel Dayer
Brian M Feldman
Waldemar Pruzanski
Pascale Roux-Lombard
Rayfel Schneider
Ronald M Laxer
In this issue
Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Mohammed A Muzaffer, Jean-Michel Dayer, Brian M Feldman, Waldemar Pruzanski, Pascale Roux-Lombard, Rayfel Schneider, Ronald M Laxer, Earl D Silverman
The Journal of Rheumatology May 2002, 29 (5) 1071-1078;
Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Mohammed A Muzaffer, Jean-Michel Dayer, Brian M Feldman, Waldemar Pruzanski, Pascale Roux-Lombard, Rayfel Schneider, Ronald M Laxer, Earl D Silverman
The Journal of Rheumatology May 2002, 29 (5) 1071-1078;